| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Dexamethasone acetate |
Is a |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone measurement |
Component |
True |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Dexamethasone adverse reaction |
Causative agent (attribute) |
True |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Topical dexamethasone adverse reaction |
Causative agent (attribute) |
True |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Topical compound dexamethasone preparation adverse reaction |
Causative agent (attribute) |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Allergy to dexamethasone |
Causative agent (attribute) |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Topical dexamethasone allergy |
Causative agent (attribute) |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Topical compound dexamethasone preparation allergy |
Causative agent (attribute) |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone overdose |
Causative agent (attribute) |
True |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Accidental dexamethasone overdose (disorder) |
Causative agent (attribute) |
True |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Intentional dexamethasone overdose |
Causative agent (attribute) |
True |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| surdose de dexaméthasone d'intention indéterminée |
Causative agent (attribute) |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Dexamethasone [endocrine use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone 500 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone 2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone 100 microgram/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone 2mg/5mL s/f oral solution (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone 2mg/5mL liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Oral dexamethasone (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing dexamethasone in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing dexamethasone in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone 1 mg/mL cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone 10mg/25g |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely dexamethasone 750 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone 4 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone 0.5mg/5mL elixir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone + neomycin sulfate + polymyxin b sulfate 0.1%wv/ns/10000unt ointment (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone + neomycin sulfate + polymyxin b sulphate 0.1%wv/ns/10000unt suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone + neomycin sulphate 1mg/3.5mg ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone + tobramycin 0.1%wv/0.3%wv suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone + tobramycin 1mg/3mg ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone sodium phosphate 24mg injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone sodium phosphate 4mg injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone sodium phospha 10mg injection solution vial (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone ophthalmic preparation |
Is a |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone nasal preparation |
Is a |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Desoximetasone (substance) |
Is a |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone phosphate |
Is a |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone sodium phosphate (substance) |
Is a |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing dexamethasone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Dexamethasone-21-isonicotinate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone+hypromellose 0.1%/0.5% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone 0.1% preservative-free eye drops (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely dexamethasone 1 milligram/1 milliliter conventional release eye drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Topical compound dexamethasone preparation (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing dexamethasone in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing dexamethasone in nasal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Dexamethasone compound eye ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone 1 mg/mL and tobramycin 3 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing dexamethasone and tobramycin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Dexamethasone sodium phospha 1mg/cc solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely dexamethasone 1 milligram/1 milliliter conventional release eye suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone sodium phosphate 1.0mg/mL ophthalmic solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| médicament contenant dexaméthasone et néomycine et polymyxine B |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Tramazoline hydrochloride+dexamethasone isonicotinate (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely dexamethasone isonicotinate 20 microgram and tramazoline hydrochloride 120 microgram/1 actuation conventional release nasal spray (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ciprofloxacin- and dexamethasone-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ciprofloxacin 0.3% + dexamethasone 0.1% sterile otic suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone 250 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely dexamethasone 1.5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely dexamethasone 6 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing dexamethasone and tramazoline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Dexamethasone sodium phospha + lidocaine hydrochloride 0ns/10mg (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing dexamethasone in otic dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing dexamethasone in respiratory dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone 500 microgram/mL and tobramycin 3 mg/mL eye suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone 700 microgram prolonged-release ocular implant |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Topical compound dexamethasone preparation allergy |
Causative agent (attribute) |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Allergy to dexamethasone |
Causative agent (attribute) |
True |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Topical dexamethasone allergy |
Causative agent (attribute) |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Dexamethasone 500 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Dexamethasone 500 microgram oral tablet |
Has basis of strength substance (attribute) |
True |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Dexamethasone 2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Dexamethasone 2 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely dexamethasone 750 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely dexamethasone 750 microgram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Dexamethasone 4 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Dexamethasone 4 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Dexamethasone 250 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Dexamethasone 250 microgram oral tablet |
Has basis of strength substance (attribute) |
True |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely dexamethasone 1.5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely dexamethasone 1.5 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely dexamethasone 6 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely dexamethasone 6 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Dexamethasone sodium metasulfobenzoate (substance) |
Is a |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone sodium metasulfobenzoate (substance) |
Is modification of (attribute) |
True |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone acetate |
Is modification of (attribute) |
True |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone phosphate |
Is modification of (attribute) |
True |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone sodium phosphate (substance) |
Is modification of (attribute) |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ciprofloxacin (as ciprofloxacin hydrochloride) 3 mg/mL and dexamethasone 1 mg/mL ear suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone 4 mg oral tablet |
Has precise active ingredient |
True |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Dexamethasone 250 microgram oral tablet |
Has precise active ingredient |
True |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely dexamethasone 1.5 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely dexamethasone 6 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Dexamethasone 500 microgram oral tablet |
Has precise active ingredient |
True |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Dexamethasone 2 mg oral tablet |
Has precise active ingredient |
True |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely dexamethasone 750 microgram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Dexamethasone isonicotinate (substance) |
Is modification of (attribute) |
True |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone 100 microgram/mL oral solution |
Has precise active ingredient |
True |
Dexamethasone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]